首页|期刊导航|吉林中医药|基于"态靶辨治"的平性靶药内涵与研究体系构建

基于"态靶辨治"的平性靶药内涵与研究体系构建OA

The connotation and research system construction of targeted neutral Chinese medicines based on the state-target differentiation and treatment framework

中文摘要英文摘要

平性靶药执中而济,具有"随证而化""打靶力专""性平用广"的特征.伴随着中西医深度融合的进程,当代临床诊疗模式逐渐转型,中医既要发挥改善症状和体征的传统优势,又亟须重视客观指标的改善.在此背景下,平性靶药展现出重要的临床价值与广阔的研究前景.本文在态靶辨治理论指导下明确"平性靶药"的概念、内涵与特色优势,提出其发掘思路与临床转化路径,以期为中药现代化研究提供理论支撑.

Targeted neutral Chinese medicines(TNCMs),characterized by their applicability due to their mild nature,exhibit the features of"adapting to various symptoms through rational compatibility","well-defined targeted effect",and"broad applicability due to their neutral properties".Alongside with the deep integration of traditional Chinese medicine(TCM)and modern medicine,contemporary clinical diagnostic and therapeutic models are undergoing a transformation.TCM need not only leverage its advantages in improving symptoms and signs,but also prioritize the enhancement of microcosmic indicators.This shift is essential to aligning with the evolving demands of medical development.In this context,TNCMs have exhibited significant clinical value and extensive research potential.This paper explores TNCMs under the state-target differentiation and treatment framework,clarifying their concepts,connotations and characteristic advantages,and proposing their exploration ideas and clinical transformation paths,in order to provide theoretical support for the modernization research of traditional Chinese medicine.

许圣贤;唐程;高文雅;谢伟楠;刘源鸿;王涵

长春中医药大学中医学院,长春 130117北京中医药大学北京中医药研究院,北京 100029北京中医药大学北京中医药研究院,北京 100029北京中医药大学研究生院,北京 100029||中国中医科学院广安门医院代谢病研究所,北京 100053北京中医药大学研究生院,北京 100029||中国中医科学院广安门医院代谢病研究所,北京 100053北京中医药大学中药学院,北京 100029

医药卫生

平性靶药态靶辨治症靶标靶中药现代化研究

targeted neutral Chinese medicinesstate-target differentiation and treatmentsymptom targetbiochemical indicator targetmodernization research of traditional Chinese medicine

《吉林中医药》 2026 (4)

491-494,4

国家自然基金委-中国科学院联合项目资助中西医结合创新范式战略研究项目(XK2023SMC003)中国科协青年人才托举工程项目(CACM-2024-QNRC1-01)长春中医药大学附属医院医学中心建设基金项目(DXZX-02-01)

10.13463/j.cnki.jlzyy.2026.04.020

评论